logo National Center of Continuing Education

Infection Control

Online Course #9008 or #5008 - 10 Contact Hours
Author: Patti V. Hoffman, RN, BS, MPH
©2008 National Center of Continuing Education, Inc.

decorative gif

For your convenience, this course has been divided into 3 sections:
Below is Part 3 of 3.
Table of ContentsReview Part 1Review Part 2Independent AnalysisEvaluation

SpacerYou may print this course or save it to your hard drive if desired. You can return later to take your Independent Analysis and submit it for fast processing. Once you have submitted your Independent Analysis, you will see your results immediately. Your certificate will be mailed First Class after we receive your completed Independent Analysis Evaluation.
SpacerThe "No Electronic Theft Act" makes it a felony to download copyrighted material over the Internet without permission. National Center of Continuing Education, Inc. grants permission for a single download of our on-line course(s) to your computer solely for the use of obtaining continuing education credits. Details on the copyright usage of our courses are specified at the end of this page.


Infection Control Practices in Non-Hospital Settings

Long Term Care
spacerOn any given day in the United States, more patients are in long-term care settings than are in acute care facilities. Most long-term care is provided in nursing homes to elderly patients, but some facilities provide psychiatric as well as medical care, to the young as well as to the old. Residents of long term care facilities present with a range of functional disability and disease, and infections are common. The most frequent endemic infections are respiratory tract, urinary tract, skin and soft tissue, and gastrointestinal tract, primarily manifesting as diarrhea. Common causes of gastrointestinal outbreaks are E. coli and salmonella, as well as the small round enteric viruses. The most frequent infections involve the urinary tract, and prevalence rates range from 25% to 50% even though most patients are asymptomatic. Respiratory tract infections may include sinusitis, pharyngitis, bronchitis, and pneumonia; the latter is the only infection in the long-term care setting that is often fatal. Outbreaks of respiratory infection caused by influenza A are common. Skin and soft tissue infections include decubitus ulcers and infected vascular and diabetic foot ulcers; non-bacterial causes of skin infection include candidiasis and herpes zoster. Scabies is often present and difficult to contain.
spacerNursing home residents seem particularly at risk for colonization with antimicrobial drug-resistant organisms, although the colonization usually occurs in a visit to an acute care setting. Some long-term facilities have reported colonization rates with MRSA as high as 30%.
spacerInfection control can be quite problematic in long-term settings for a variety of reasons. Residents of these facilities are often highly functionally impaired; they may be incontinent, immobile, and confused or demented. The worse their functional status, the greater the likelihood of infection or colonization with resistant organisms. Since in most cases the functional impairment has led to admission to the care facility and is in most instances unmodifiable, it may be unrealistic to believe that endemic infections can be prevented among these residents to a significant degree. A series of clinical studies has demonstrated the limited effectiveness of a variety of infection control approaches in long term facilities, including vitamin supplementation, routine vs prn percutaneous feeding tube changes, clean vs sterile intermittent catheterization technique, and aggressive treatment to eradicate MRSA colonization. Further evaluation of the effectiveness of specific interventions is needed.
spacerAnother compounding circumstance is the increasing admission to long term care of patients with invasive devices. Appropriate treatment and infection control guidelines need to be developed in each facility for those patients with chronic tracheostomies and respiratory care needs, central lines, and percutaneous feeding tubes, among others.

Home Care
spacerProvision of home care services has also expanded exponentially in the last decade, due to efforts to decrease hospital lengths of stay and shift care to ambulatory settings. Today there are approximately 10,000 agencies that provide home care. Most patients are elderly, with chronic conditions that require skilled care. However, a substantial proportion of home care patients are younger and may include postoperative patients, postpartum mothers and their babies, and patients with acute medical conditions such as diabetes and recent strokes. Services provided may include infusion therapy, tracheostomy care and ventilator support, dialysis, and other invasive procedures.
spacerLimited data are available on the incidence of home-acquired infections and analysis of risk factors, so development of infection control programs specific to the home environment is difficult. Although the home care patient may have less clinical acuity in terms of the degree or intensity of care needed, and less exposure to nosocomial pathogens, there may be other substantial risk factors to be considered. The home care patient may be of advanced age, and may have chronic diseases and reduced immune activity. The care provided by family members is likely to be less structured and controlled, and the environment may be lacking in proper sanitation and ventilation.
spacerGiven the relative risks encountered in the home environment and the nature of the interventions, infection control strategies in the home care setting should focus on infusion therapy, urinary tract care, respiratory care, wound care, and enteral therapy. Practices recommended for intravenous therapy in the hospital setting should work well in the home. Procedures for dealing with urinary catheters should, however, be adapted to the specific circumstances of each home patient.
spacerWound care may be a significant challenge. Home care patients may have a variety of wounds, such as stasis ulcers and pressure sores which are commonly colonized with gram negative flora; this increases the possibility that the patient's new wounds may become infected with his own organisms. Thus, the procedures for wound care in the home should be based on a careful assessment of the real potential for contamination and infection.
spacerEnteral therapy at home presents a risk for gastrointestinal infection. Reduction of this risk may require considerable patient and family teaching with regard to the need for refrigeration of the feeding and scrupulous cleaning of all items used in its preparation, but sterilization of appliances and kitchen tools is probably not necessary.
spacerStandard precautions should always be followed, just as with hospital-based patients. The use of gloves and gowns in the home care setting, however, is more likely to be for the protection of the nurse rather than the patient, and mask use may be limited to those patients with pulmonary tuberculosis.
spacerA home care nurse who is treating a patient with multidrug-resistant organisms should be alert to the need for use of appropriate barriers. Reusable equipment should be dedicated to the use of that particular patient and left in the home. The nurse should plan to see the patient as the last appointment of the day, or at least after seeing patients at increased risk, such as those receiving wound care. Further study is needed to identify significant risks and appropriate risk reduction strategies for use in the home care setting.

Dialysis Units
spacerThe number of patients with end-stage renal disease treated by maintenance hemodialysis in the United States has increased sharply during the past 30 years. In an environment where multiple patients receive dialysis concurrently, repeated opportunities exist for person-to-person transmission of infectious agents, directly or indirectly, via contaminated devices, equipment and supplies; environmental surfaces; or hands of personnel. The CDC has developed the following recommendations to minimize the spread of disease in these settings:

  • Wear disposable gloves when caring for the patient or touching the patient's equipment at the dialysis station; remove gloves and wash hands between patients or stations.
  • Items taken into the dialysis station should either be disposed of, dedicated for use only on a single patient, or cleaned and disinfected before being taken to a common clean area or used on another patient.
    • Nondisposable items that cannot be cleaned and disinfected (e.g., adhesive tape, cloth-covered blood pressure cuffs) should be dedicated for use only on a single patient.
    • Unused medications (including multiple dose vials containing diluents) or supplies (syringes, alcohol swabs, etc.) taken to the patient's station should be used only for that patient and should not be returned to a common clean area or used on other patients.
  • When multiple dose medication vials are used (including vials containing diluents), prepare individual patient doses in a clean (centralized) area away from dialysis stations and deliver separately to each patient. Do not carry multiple dose medication vials from station to station.
  • Do not use common medication carts to deliver medications to patients. Do not carry medication vials, syringes, alcohol swabs or supplies in pockets. If trays are used to deliver medications to individual patients, they must be cleaned between patients.
  • Clean areas should be clearly designated for the preparation, handling and storage of medications and unused supplies and equipment. Clean areas should be clearly separated from contaminated areas where used supplies and equipment are handled. Do not handle and store medications or clean supplies in the same or an adjacent area to that where used equipment or blood samples are handled.
  • Use external venous and arterial pressure transducer filters/protectors for each patient treatment to prevent blood contamination of the dialysis machine's pressure monitors. Change filters/protectors between patient treatments, and do not reuse them. Internal transducer filters do not need to be changed routinely between patients.
  • Clean and disinfect the dialysis station (chairs, beds, tables, machines, etc.) between patients.
    • Give special attention to cleaning control panels on the dialysis machines and other surfaces that are frequently touched and potentially contaminated with patients' blood.
    • Discard all fluid and clean and disinfect all surfaces and containers associated with the prime waste (including buckets attached to the machines).
  • For dialyzers and blood tubing that will be reprocessed, cap dialyzer ports and clamp tubing. Place all used dialyzers and tubing in leak-proof containers for transport from station to reprocessing or disposal area.

spacerAll dialysis patients should undergo routine testing for Hepatitis B (HBV) and Hepatitis C (HCV) infections, according to the following schedule:


Schedule for Routine Testing for HBV and HCV Infections

Patient Status

On Admission
Monthly
Semi-Annual
Annual
All patients HBsAg,
Anti-HBc (total)
Anti-HBs,
Anti-HCV, ALT
     
HBV susceptible, including non-responders to vaccine  
HbsAg
   
Anti-HBs positive (>10mIU/mL), anti-HBc negative      
Anti-HBs

Anti-HBs and anti-HBc positive

No additional HBV testing needed
Anti-HCV negative  
ALT
Anti-HCV
 

spacerAll patients should be vaccinated against Hepatitis B. Each patient should then be tested for anti-HBs one to two months after the last dose. If anti-HBs is <10 mIU/mL, consider patient susceptible, revaccinate with an additional three doses, and retest for anti-HBs. If anti-HBs is >10 mIU/mL, consider the patient immune, and retest annually. If anti-HBs declines to <10 mIU/mL at any time, give the patient a booster dose of vaccine and continue to retest annually.
spacerHBsAg-positive patients should be treated according to the unit's infection control practices for all patients. In addition, these patients should be dialyzed in a separate room using separate machines, equipment, instruments, and supplies. Staff members caring for HBsAg-positive patients should not care for HBV susceptible patients at the same time (e.g., during the same shift or during patient change-over).

Precautions in the Dental Setting
spacerThe dental caregiver has unique requirements and should place special emphasis on the following precautions to prevent exposure to bloodborne pathogens in institutional and non-institutional dental settings.

  1. In addition to wearing gloves for contact with the oral mucous membranes of all dental patients, all dental caregivers should wear surgical masks and protective eyewear or chin-length plastic shields during dental procedures in which splashing or spattering of blood, saliva, or gingival fluids is likely. Rubber dams, high-speed evacuation, and proper patient positioning should be utilized to minimize generation of droplets and spatter.
  2. Dental handpieces should be sterilized after each use with patients because blood, saliva or gingival fluid may be aspirated into the handpiece or waterline. If handpieces cannot be sterilized, they should be flushed for at least 20-30 seconds to discharge water and air from the lines. The outside surface of the handpiece should be cleaned and wiped with a suitable chemical germicide and rinsed. Handpieces should be flushed at the beginning of each working day and after use with each patient. Handpieces that cannot be sterilized should be replaced or retrofitted with heat stable components to permit sterilization as soon as feasible. As with other equipment, the manufacturer's instructions should always be followed. The dental caregiver should follow the same precautions for other reusable intraoral instruments attached to, but removable from the dental unit air or water lines such as ultrasonic scalers and air/water syringes.
  3. All blood and saliva should be thoroughly and carefully cleaned from material that has been used in the mouth (impression materials, bite registration, etc.), especially before polishing and grinding intraoral devices. All contaminated materials, impressions, and intraoral devices should be cleaned and disinfected prior to being handled in the dental laboratory and before they are placed in the patient's mouth. Dental workers should consult with manufacturers to determine the appropriate disinfectant for each material used.
  4. All dental equipment and surfaces that are difficult to disinfect (e.g., light handles or x-ray unit heads) and that may become contaminated should be wrapped with impervious-backed paper, aluminum foil, or clear plastic wrap. The coverings should be removed and discarded, and clean coverings should be put in place after use with each patient.

The Caregiver and Infection Control

spacerAfter all of the facts have been presented in any infection control program and after all of the suggestions and requirements for preventing the transmission of disease have been made, there remains one controlling factor. That factor is vital in order for any program, no matter how well planned or presented, to be successful. That factor is YOU, the caregiver. You are the most important part of any infection control program because you are the one who makes it function properly. Without your dedication in application of the program, it is doomed to failure. The foregoing facts and requirements will assist you in assuring that your infection control program is successful.


APPENDIX A

Type and Duration of Precautions Needed for Selected Infections and Conditions

  Precautions
Infection/Condition
Type* Duration
Abscess    
    Draining, major a C DI
    Draining, minor or limited b S  
Acquired immunodeficiency syndrome c S  
Actinomycosis S  
Adenovirus infection, in infants and young children D,C DI
Amebiasis S  
Anthrax    
    Cutaneous S  
    Pulmonary S  
Antibiotic-associated colitis (see Clostridium difficile)    
Arthropodborne viral encephalitides (eastern, western, Venezuelan equine encephalomyelitis; St Louis, California encephalitis) S d  
Arthropodborne viral fevers (dengue, yellow fever, Colorado tick fever) S d  
Ascariasis S  
Aspergillosis S  
Babesiosis S  
Blastomycosis, North American, cutaneous or pulmonary S  
Botulism S  
Bronchiolitis (see respiratory infections in infants and young children)    
Brucellosis (undulant, Malta, Mediterranean fever) S  
Campylobacter gastroenteritis (see gastroenteritis)    
Candidiasis, all forms including mucocutaneous S  
Cat-scratch fever (benign inoculation lymphoreticulosis) S  
Cellulitis, uncontrolled drainage C DI
Chancroid (soft chancre) S  
Chickenpox (varicella; see F e for varicella exposure) A,C F e
Chlamydia trachomatis    
    Conjunctivitis S  
    Genital S  
    Respiratory S  
Cholera (see gastroenteritis)    
Closed-cavity infection    
    Draining, limited or minor S  
    Not draining S  
Clostridium    
    C botulinum S  
    C difficile C DI
    C perfringens    
        Food poisoning S  
        Gas gangrene S  
Coccidioidomycosis (valley fever)    
    Draining lesions S  
    Pneumonia S  
Colorado tick fever S  
Congenital rubella C F f
Conjunctivitis    
    Acute bacterial S  
    Chlamydia S  
    Gonococcal S  
    Acute viral (acute hemorrhagic) C DI
Coxsackievirus disease (see enteroviral infection)    
Creutzfeldt-Jakob disease S g  
Croup (see respiratory infections in infants and young children)    
Cryptococcosis S  
Cryptosporidiosis (see gastroenteritis)    
Cysticercosis S  
Cytomegalovirus infection, neonatal or immunosuppressed S  
Decubitus ulcer, infected  
    Major a C DI
    Minor or limited b S  
Dengue S d  
Diarrhea, acute-infective etiology suspected (see gastroenteritis)    
Diphtheria    
    Cutaneous C CN h
    Pharyngeal D CN h
Ebola viral hemorrhagic fever C i DI
Echinococcosis (hydatidosis) S  
Echovirus (see enteroviral infection)    
Encephalitis or encephalomyelitis (see specific etiologic agents)  
Endometritis S  
Enterobiasis (pinworm disease, oxyuriasis) S  
Enterococcus species (see multidrug-resistant organisms if epidemiologically significant or vancomycin resistant)    
Enterocolitis, Clostridium difficile C DI
Enteroviral infections    
    Adults S  
    Infants and young children C DI
Epiglottitis, due to Haemophilus influenzae D U(24 hrs)
Epstein-Barr virus infection, including infectious mononucleosis S  
Erythema infectiosum (also see Parvovirus B19) S  
Escherichia coli gastroenteritis (see gastroenteritis)    
Food poisoning    
    Botulism S  
    Clostridium perfringens or welchii S  
    Staphylococcal S  
Furunculosis-staphylococcal    
    Infants and young children C DI
Gangrene (gas gangrene) S  
Gastroenteritis    
    Campylobacter species S j  
    Cholera S j  
    Clostridium difficile C DI
    Cryptosporidium species S j  
    Escherichia coli    
        Enterohemorrhagic O157:H7 S j  
            Diapered or incontinent C DI
        Other species S j  
    Giardia lamblia S j  
    Rotavirus S j  
        Diapered or incontinent C DI
     Salmonella species (including S typhi) S j  
     Shigella species S j  
        Diapered or incontinent C DI
    Vibrio parahaemolyticus S j  
    Viral (if not covered elsewhere) S j  
    Yersinia enterocolitica S j  
German measles (see rubella)    
Giardiasis (see gastroenteritis)    
Gonococcal ophthalmia neonatorum (gonorrheal ophthalmia, acute conjunctivitis of newborn) S  
Gonorrhea S  
Granuloma inguinale (donovanosis, granuloma venereum) S  
Guillain-Barré, syndrome S  
Hand, foot, and mouth disease (see enteroviral infection)    
Hantavirus pulmonary syndrome S  
Helicobacter pylori S  
Hemorrhagic fevers (for example, Lassa and Ebola) C i DI
Hepatitis, viral    
    Type A S  
        Diapered or incontinent patients C F k
    Type B-HBsAg positive S  
    Type C and other unspecified non-A, non-B S  
    Type E S  
Herpangina (see enteroviral infection)    
Herpes simplex (Herpesvirus hominis)    
    Encephalitis S  
    Neonatal l (see F l for neonatal exposure) C DI
    Mucocutaneous, disseminated or primary, severe C DI
    Mucocutaneous, recurrent (skin, oral, genital) S  
Herpes zoster (varicella-zoster)    
    Localized in immunocompromised patient, or disseminated A,C DI m
    Localized in normal patient S m  
Histoplasmosis S  
HIV (see human immunodeficiency virus) S  
Hookworm disease (ancylostomiasis, uncinariasis) S  
Human immunodeficiency virus (HIV) infection c S  
Impetigo C U(24 hrs)
Infectious mononucleosis S  
Influenza D n DI
Kawasaki syndrome S  
Lassa fever C i DI
Legionnaires' disease S 
Leprosy S 
Leptospirosis S 
Lice (pediculosis) C U(24 hrs)
Listeriosis S 
Lyme disease S 
Lymphocytic choriomeningitis S 
Lymphogranuloma venereum S 
Malaria S d 
Marburg virus disease C i DI
Measles (rubeola), all presentations A DI
Melioidosis, all forms S 
Meningitis  
    Aseptic (nonbacterial or viral meningitis; also see enteroviral infections) S 
     Bacterial, gram-negative enteric, in neonates S 
    Fungal S 
    Haemophilus influenzae, known or suspected D U(24 hrs)
    Listeria monocytogenes S 
    Neisseria meningitidis (meningococcal) known or suspected D U(24 hrs)
    Pneumococcal S 
    Tuberculosis o S 
    Other diagnosed bacterial S 
Meningococcal pneumonia D U(24 hrs)
Meningococcemia (meningococcal sepsis) D U(24 hrs)
Molluscum contagiosum S 
Mucormycosis S 
Multidrug-resistant organisms, infection or colonization p  
    Gastrointestinal C CN
    Respiratory C CN
        Pneumococcal S 
    Skin, wound, or burn C CN
Mumps (infectious parotitis) D F q
Mycobacteria, nontuberculosis (atypical)  
    Pulmonary S 
    Wound S 
Mycoplasma pneumonia D DI
Necrotizing enterocolitis S 
Nocardiosis, draining lesions or other presentations S 
Norwalk agent gastroenteritis (see viral gastroenteritis)  
Orf S 
Parainfluenza virus infection, respiratory in infants and young children C DI
Parvovirus B19 D F r
Pediculosis (lice) C U(24 hrs)
Pertussis (whooping cough) D F s
Pinworm infection S 
Plague  
    Bubonic S 
    Pneumonic D U(72 hrs)
Pleurodynia (see enteroviral infection)  
Pneumonia  
    Adenovirus D,C DI
    Bacterial not listed elsewhere (including gram-negative bacterial) S 
    Burkholderia cepacia in cystic fibrosis (CF) patients, including respiratory tract colonization S t 
    Chlamydia S 
    Fungal S 
    Haemophilus influenzae  
        Adults S 
        Infants and children (any age) D U(24 hrs)
    Legionella S 
    Meningococcal D U(24 hrs)
    Multidrug-resistant bacterial (see multidrug-resistant organisms)  
    Mycoplasma (primary atypical pneumonia) D DI
    Pneumococcal S 
        Multidrug-resistant (see multidrug-resistant organisms)  
    Pneumocystis carinii S u 
    Pseudomonas cepacia (see Burkholderia cepacia) S t 
    Staphylococcus aureus S 
    Streptococcus, group A  
        Adults S 
        Infants and young children D U(24hrs)
    Viral  
        Adults S 
        Infants and young children (see respiratory infectious disease, acute)  
Poliomyelitis S 
Psittacosis (ornithosis) S 
Q fever S 
Rabies S 
Rat-bite fever (Streptobacillus moniliformis disease, Spirillum minus disease) S 
Relapsing fever S 
Resistant bacterial infection or colonization (see multidrug-resistant organisms)  
Respiratory infectious disease, acute (if not covered elsewhere)  
    Adults S 
    Infants and young children c C DI
Respiratory syncytial virus infection, in infants and young children, and immunocompromised adults C DI
Reye's syndrome S 
Rheumatic fever S 
Rickettsial fevers, tickborne (Rocky Mountain spotted fever, tickborne typhus fever) S 
Rickettsialpox (vesicular rickettsiosis) S 
Ringworm (dermatophytosis, dermatomycosis, tinea) S 
Ritter's disease (staphylococcal scalded skin syndrome) S 
Rocky Mountain spotted fever S 
Roseola infantum (exanthem subitum) S 
Rotavirus infection (see gastroenteritis)  
Rubella (German measles; also see congenital rubella) D F v
Salmonellosis (see gastroenteritis)  
Scabies C U(24 hrs)
Scalded skin syndrome, staphylococcal (Ritter's disease) S 
Schistosomiasis (bilharziasis) S 
Shigellosis (see gastroenteritis)  
Sporotrichosis S 
Spirillum minus disease (rat-bite fever) S 
Staphylococcal disease (S aureus)  
    Skin, wound, or burn  
        Major a C DI
        Minor or limited b S 
    Enterocolitis S j 
    Multidrug-resistant (see multidrug-resistant organisms)  
    Pneumonia S 
    Scalded skin syndrome S 
    Toxic shock syndrome S 
Streptobacillus moniliformis disease (rat-bite fever) S 
Streptococcal disease (group A streptococcus)  
    Skin, wound, or burn  
        Major a C U(24 hrs)
        Minor or limited b S 
    Endometritis (puerperal sepsis) S 
    Pharyngitis in infants and young children D U(24 hrs)
    Pneumonia in infants and young children D U(24 hrs)
    Scarlet fever in infants and young children D U(24 hrs)
Streptococcal disease (group B streptococcus), neonatal S 
Streptococcal disease (not group A or B) unless covered elsewhere S 
    Multidrug-resistant (see multidrug-resistant organisms)  
Strongyloidiasis S 
Syphilis  
    Skin and mucous membrane, including congenital, primary, secondary S 
    Latent (tertiary) and seropositivity without lesions S 
Tapeworm disease  
    Hymenolepis nana S 
    Taenia solium (pork) S 
    Other S 
Tetanus S 
Tinea (fungus infection dermatophytosis, dermatomycosis, ringworm) S 
Toxoplasmosis S 
Toxic shock syndrome (staphylococcal disease) S 
Trachoma, acute S 
Trench mouth (Vincent's angina) S 
Trichinosis S 
Trichomoniasis S 
Trichuriasis (whipworm disease) S 
Tuberculosis  
    Extrapulmonary, draining lesion (including scrofula) S 
    Extrapulmonary, meningitis o S 
    Pulmonary, confirmed or suspected or laryngeal disease A F w
    Skin-test positive with no evidence of current pulmonary disease S 
Tularemia  
    Draining lesion S 
    Pulmonary S 
Typhoid (Salmonella typhi) fever (see gastroenteritis)
Typhus, endemic and epidemic S 
Urinary tract infection (including pyelonephritis), with or without urinary catheter S 
Varicella (chickenpox) A,C F e
Vibrio parahaemolyticus (see gastroenteritis)  
Vincent's angina (trench mouth) S 
Viral diseases  
    Respiratory (if not covered elsewhere)  
        Adults S 
        Infants and young children (see respiratory infectious disease, acute)  
Whooping cough (pertussis) D F s
Wound infections  
    Major a C DI
    Minor or limited b S 
Yersinia enterocolitica gastroenteritis (see gastroenteritis)  
Zoster (varicella-zoster)  
    Localized in immunocompromised patient, disseminated A,C DI m
    Localized in normal patient S m 
Zygomycosis (phycomycosis, mucormycosis) S 

Abbreviations:

* Type of Precautions: A, Airborne; C, Contact; D, Droplet; S, Standard; when A, C, and D are specified, also use S.
Duration of precautions: CN, until off antibiotics and culture-negative; DI, duration of illness (with wound lesions, DI means until they stop draining); U, until time specified in hours (hrs) after initiation of effective therapy; F, see footnote.
a No dressing or dressing does not contain drainage adequately.
b Dressing covers and contains drainage adequately.
c Also see syndromes or conditions listed in Table 5.
d Install screens in windows and doors in endemic areas.
e Maintain precautions until all lesions are crusted. The average incubation period for varicella is 10 to 16 days, with a range of 10 to 21 days. After exposure, use varicella zoster immune globulin (VZIG) when appropriate, and discharge susceptible patients if possible. Place exposed susceptible patients on Airborne Precautions beginning 10 days after exposure and continuing until 21 days after last exposure (up to 28 days if VZIG has been given). Susceptible persons should not enter the room of patients on precautions if other immune caregivers are available.
f Place infant on precautions during any admission until 1 year of age, unless nasopharyngeal and urine cultures are negative for virus after age 3 months.
g Additional special precautions are necessary for handling and decontamination of blood, body fluids and tissues, and contaminated items from patients with confirmed or suspected disease. See latest College of American Pathologists (Northfield, Illinois) guidelines or other references.
h Until two cultures taken at least 24 hours apart are negative.
i Call state health department and CDC for specific advice about management of a suspected case. During the 1995 Ebola outbreak in Zaire, interim recommendations were published.(97) Pending a comprehensive review of the epidemiologic data from the outbreak and evaluation of the interim recommendations, the 1988 guidelines for management of patients with suspected viral hemorrhagic infections (16) will be reviewed and updated if indicated.
j Use Contact Precautions for diapered or incontinent children <6 years of age for duration of illness.
k Maintain precautions in infants and children <3 years of age for duration of hospitalization; in children 3 to 14 years of age, until 2 weeks after onset of symptoms; and in others, until 1 week after onset of symptoms.
l For infants delivered vaginally or by C-section and if mother has active infection and membranes have been ruptured for more than 4 to 6 hours.
m Persons susceptible to varicella are also at risk for developing varicella when exposed to patients with herpes zoster lesions; therefore, susceptibles should not enter the room if other immune caregivers are available.
n The "Guideline for Prevention of Nosocomial Pneumonia" (95,96) recommends surveillance, vaccination, antiviral agents, and use of private rooms with negative air pressure as much as feasible for patients for whom influenza is suspected or diagnosed. Many hospitals encounter logistic difficulties and physical plant limitations when admitting multiple patients with suspected influenza during community outbreaks. If sufficient private rooms are unavailable, consider cohorting patients or, at the very least, avoid room sharing with high-risk patients. See "Guideline for Prevention of Nosocomial Pneumonia" (95,96) for additional prevention and control strategies.
o Patient should be examined for evidence of current (active) pulmonary tuberculosis. If evidence exists, additional precautions are necessary (see tuberculosis).
p Resistant bacteria judged by the infection control program, based on current state, regional, or national recommendations, to be of special clinical and epidemiologic significance.
q For 9 days after onset of swelling.
r Maintain precautions for duration of hospitalization when chronic disease occurs in an immunodeficient patient. For patients with transient aplastic crisis or red-cell crisis, maintain precautions for 7 days.
s Maintain precautions until 5 days after patient is placed on effective therapy.
t Avoid cohorting or placement in the same room with a CF patient who is not infected or colonized with B cepacia. Persons with CF who visit or provide care and are not infected or colonized with B cepacia may elect to wear a mask when within 3 ft of a colonized or infected patient.
u Avoid placement in the same room with an immunocompromised patient.
v Until 7 days after onset of rash.
w Discontinue precautions only when TB patient is on effective therapy, is improving clinically, and has three consecutive negative sputum smears collected on different days, or TB is ruled out. Also see CDC
"Guidelines for Preventing the Transmission of Tuberculosis in Health-Care Facilities."


From the Public Health Service, US Department of Health and Human Services, Centers for Disease Control and Prevention, Atlanta, Georgia. See Garner JS, Hospital Infection Control Practices Advisory Committee. Guideline for isolation precautions in hospitals. Infect Control Hosp Epidemiol 1996; 17:53-80, and Am J Infect Control 1996; 24:24-52.

You have Finished Part 3 of 3. Click on Independent Analysis or Evaluation to continue.

Table of ContentsReview Part 1Review Part 2Independent AnalysisEvaluation


National Center Notice:
SpacerExtraordinary efforts have been made by authors, the editor, and the publisher of this course to insure dosage recommendations and treatments are precise and agree with the highest standards of practice. However, as a result of accumulating clinical experience and continuing laboratory studies, dosage schedules and/or treatment recommendations are often altered or discontinued. This is most likely to occur with newly introduced products or as a result of new research findings. We urge you to check the package information of all medications and comply with the manufacturer's recommended dosage. In all cases the advice of a physician should be sought and followed concerning initiating or discontinuing all medications or treatments. The author, editor, and publisher disclaim any responsibility for any adverse effects resulting from the information contained in this course material.
SpacerAll rights reserved. No part of this publication may be reproduced; stored in a retrieval system; or transmitted in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise; without the prior written permission of copyright holder.



National Center of Continuing Education, Inc.

Home | Site map | Order | Order Offline | Course Descriptions | Online Courses | New Online Courses | Begin Online Course | Instructions | Accreditation | Free Catalog | Testimonials | Contact Us | Survey


COPYRIGHT ©2008 National Center of Continuing Education, Inc. All rights reserved. No part of this publication may be reproduced, stored in a retrieval system or transmitted in any form or by any mechanical or electronic means, photocopying, recording or otherwise, without prior written permission of copyright holder. "Convenience and a Choice..." is a service mark (SM) of the National Center of Continuing Education, Inc.